je.st
news
Home
› Tokyo Institute Of Technology And Astellas Launch Collaborative Research For New Anti-Dengue Virus Drugs For Neglected Tropical Diseases
Tokyo Institute Of Technology And Astellas Launch Collaborative Research For New Anti-Dengue Virus Drugs For Neglected Tropical Diseases
2013-03-21 04:09:00| drugdiscoveryonline News Articles
Tokyo Institute of Technology ("Tokyo Tech"; Tokyo, Japan; President: Yoshinao Mishima) and Astellas Pharma Inc. ("Astellas")(TOKYO:4503)(President and CEO: Yoshihiko Hatanaka) recently announced that they have signed a joint research agreement for drug discovery research utilizing Tokyo Tech's TSUBAME2.0 supercomputer to efficiently discover candidates for the treatment of neglected tropical diseases ("NTDs") caused by dengue virus
Tags: research
technology
institute
drugs
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||